A Case Report of Drug-Induced Myopathy Involving Extraocular Muscles After Combination Therapy With Tremelimumab and Durvalumab for Non-Small Cell Lung Cancer

Neuro-Ophthalmology - United Kingdom
doi 10.1080/01658107.2017.1291686
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

ARCTIC: Durvalumab With or Without Tremelimumab as Third-Line or Later Treatment for Metastatic Non-Small Cell Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2020English

Oncothermia in Combination With Vitamin C Infusion for Non-Small Cell Lung Cancer: A Case Report

journal of nutritional oncology
2019English

Salvage Surgery for Advanced Non-Small Cell Lung Cancer After Targeted Therapy: A Case Series

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2020English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Challenges in Bevacizumab and Gefitinib Combination Therapy for Patients With Non–Small-Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Durvalumab for Non-Resectable Stage IIIB Non-Small Cell Lung Cancer—a Small Step or a Big Leap?

Translational Lung Cancer Research
Oncology
2018English

A Decade of Targeted Therapy for Non-Small Cell Lung Cancer

2017English

Drug Combination Synergy in Worm-Like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer

ACS Nano
Materials ScienceNanoscienceEngineeringNanotechnologyAstronomyPhysics
2018English

AB034. Muscular Metastasis From Non-Small Cell Lung Cancer: A Case Report

Annals of Translational Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy